HER2 and EGFR Kinase in Cancer

Increased risk of skin cancer

Reduced risk of brain cancer

Common in pancreatic and prostate cancers

Frequent occurrence in breast, ovarian, and lung cancers (correct)

By blocking HER2 with antibodies only

By targeting cell growth indirectly

By analyzing the crystal structure of HER2-herceptin complex (correct)

By inhibiting EGFR kinase activity

In silico screening method (correct)

In vitro cell culture studies

In vivo animal trials

Chemical extraction and analysis

<p>High antiproliferative activity against breast cancer cell lines</p> Signup and view all the answers

<p>To dock analogs of HERP5 and HERP7 with HER2 protein</p> Signup and view all the answers